Tackling Disparities in Oncology Requires Action as Well as Research
In this interview, Dr. Andrea Silber discusses how the COVID-19 pandemic has exacerbated disparities that already existed within oncology care, and she said the effects of these disparities on patients are very real and direct.Source: Pharmacy Times
Breast cancer care in U.S. territories lags behind care in states
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers. Their findings were published in the March issue of Health Affairs.
Yale Cancer Center receives $1 million grant to address cancer disparities
Researchers at Yale Cancer Center (YCC) have been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support. The grant will fund the Cancer Disparities Firewall project, a multilevel intervention that focuses on patient and system level factors that contribute to cancer disparities in the YCC/New Haven, Connecticut area. The project will target lung, breast, colorectal, and prostate cancer.
Yale Study: Minority Breast Cancer Patients Less Likely To Have Genetic Test
A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.Source: Connecticut Health I-Team
Racial Disparities in Genetic Testing of Women With Breast Cancer
MedicalResearch.com Interview with: Cary P. Gross, MD Section of General Internal Medicine Yale University School of Medicine New Haven, CT MedicalResearch.com: What is the background for this study? What are the main findings? Response: Prior work has demonstrated racial and socioeconomic disparities in breast cancer diagnosis, treatment, and outcomes. As the oncology field has progressed over the past decade, the use of genetic testing to guide treatment decisions is one of the most exciting new developments.Source: Medical Research
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
Understanding Breast Cancer Disparities in the United States
At a recent Yale Cancer Center Grand Rounds lecture, Dr. Beth Jones, Research Scientist, Epidemiology and Public Health, discussed the disparities that exist in breast cancer in the United States, focusing mainly on Hispanic and Latino women. By the year 2050 Hispanic/Latinos will represent close to 1/3 of the U.S. population.
US environmental laws are cleaning up air. But benefits vary across racial groups, study finds
Poor air quality has been a major concern this year in New England, but a new Yale-led study is highlighting how certain racial groups have suffered disproportionate health impacts from air pollution for years.Source: Connecticut Public Radio
Environmental Injustice and Cumulative Environmental Burdens in Neighborhoods Near Oil and Gas Development: Los Angeles County, California, and Beyond
Residential proximity to oil and gas wells has been increasingly recognized to threaten the health and environmental quality of nearby communities.Source: American Journal of Public Health
Health inequities persist in Connecticut: 14,000 excess deaths among Black population
DataHaven’s new Health Equity in Connecticut 2023 report found that inequities resulted in 14,000 excess deaths among Connecticut’s Black population compared to its white demographic.Source: Connecticut Public Radio
Nearly 1 in 3 Black adults may develop PAD; disparities in care increase amputation risk
Routine, low-cost testing may reduce disparities and health care costs for people with peripheral artery disease (PAD), according to new American Heart Association scientific statement.Source: American Heart Association
Routine tests may reduce disparities in peripheral artery disease and amputation risk
Standard testing that is inexpensive may help reduce disparities in care and lower the amputation risk for people with peripheral artery disease, according to a new science report.Source: American Heart Association